New clinical trial designs for evaluation of antimicrobial agents


Speakers:

  • David Paterson, Director, University of Queensland Centre for Clinical Research (Australia)
  • Julie Marsh, Biostatistical Lead, Wesfarmers Centre of Vaccines and Infectious Diseases, University of Western Australia (Australia)

Moderator: Thomas Snelling, Professor of Infectious Diseases and Director of the Health and Clinical Analytics lab, Sydney School of Public Health, University of Sydney (Australia)

Presentation 1: Overview of innovations in clinical trials of antimicrobial agents (David Paterson)

  • The value proposition of clinical trial networks
  • What could MAMS, DOOR or PRACTical bring to clinical trials of antimicrobials?
  • Pros and cons of new clinical trial designs

Presentation 2: Overview of adaptive trials in vaccines & antimicrobial agents (Julie Marsh)

  • Adaptive trials
  • Understanding the decision process for trial adaptations
  • Implementation challenges
  • Trial governance & integrity

This webinar including interactive Q&A was broadcast on 27 May 2021.

If you have questions or comments, please let us know: revive@gardp.org.

Download the speakers’ slides here
2021-06-15T15:39:44+00:00